Logo
Please rotate your device

Landscape orientation recommended.

Menu

No results found.

IDX
Integral Diagnostics Limited – ASX
Weekly Share Price & Valuation Overview
Market Overview
Open
2.7600
Close
2.7100
High
2.7700
Low
2.6800
Trend
0.42118

Integral Diagnostics Limited

Australia • ASX - Australian Securities Exchange • IDX • Currency: AUD

Integral Diagnostics Limited, a healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides positron emission tomography, magnetic resonance imaging, and other radiology services. The company was founded in 1967 and is headquartered in Melbourne, Australia.

Key strengths
  • Earnings growth ≥10% supports improving profitability trajectory.
Potential weaknesses
  • Quick ratio <0.8 — tight near-term liquidity without inventory.
  • Debt/EBITDA >4 — elevated leverage vs earnings capacity.
Scale & Structure Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares. Revenue estimated from Revenue/share × Shares.
Market Cap Total equity value of the company (share price × shares outstanding).
AUD 990.66M
Enterprise Value Operating value: market cap + total debt − cash.
AUD 1.49B
Total Revenue (TTM) Estimated Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
AUD 760.50M
Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
AUD 155.53M
EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
AUD 72.90M
Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
AUD 2.04
EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
0.02
Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
2.18%
Shares Outstanding
372.43M
Float Shares
347.83M
Implied Shares Outstanding
372.43M
Profitability & Efficiency TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
8.05%
EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
9.59%
Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).
20.45%
Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
1.15%
ROA Return on assets: net income ÷ total assets.
2.56%
ROE Return on equity: net income ÷ shareholder equity.
1.14%
Growth Growth rates are YoY unless labeled QoQ.
Revenue Growth Year-over-year revenue growth.
9.30%
Earnings Growth (YoY) Strong Year-over-year earnings growth.
23.61%
Liquidity & Solvency Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
Quick Ratio Liquid current assets ÷ current liabilities (ex-inventory).
0.47
Debt to Equity Total debt ÷ shareholder equity; leverage.
0.77
Total Cash Cash and equivalents.
AUD 31.26M
Total Debt Short + long-term interest-bearing debt.
AUD 532.65M
Net Debt Total debt − cash (negative = net cash).
AUD 501.38M
Debt / EBITDA Leverage relative to operating earnings; lower is safer.
7.31
Cash Flow Shown only when internally consistent; margins are TTM.
Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
AUD 73.12M
Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
AUD 66.46M
OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
9.61%
FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
8.74%
Cash Conversion (OpCF/EBITDA)
1.00
Sharemaestro House View
Confidence: 1 Sharemaestro internal conviction (0–3, higher is better). Risk: 2 Sharemaestro internal risk profile (0–3, higher is safer). Operational: 1 Operational quality/consistency (0–3, higher is better). Composite Score: 1 Overall internal composite (0–3, higher is better). Suggested Allocation: 1.67% Indicative portfolio weighting suggestion based on house view.
Structural Insights (experimental)
Ownership & Liquidity
Free Float Proportion of shares available for public trading. 93.4%
Insiders Shares held by company insiders (officers, directors). 12.8%
Institutions Shares held by institutions (funds, pensions). 27.7%
Capital Structure
Potential Dilution Increase in share count if options/convertibles exercise.
None detected
Net Debt Total debt − cash (negative = net cash).
AUD 501.38M
65.9% of revenue Net debt relative to revenue — debt load vs business scale.
Resilience Score 0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating. 17
Methodology Notes
  • Total Revenue (TTM) estimated from Revenue per Share × Shares due to feed inconsistency.
  • Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
  • Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-08-18 10:01

Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.

AI generated insights not available yet. Sign in to generate the snapshot.